LENZ vs OGN · rev $7.4M vs P/E 3.4, rev $3.02B
LENZ Therapeutics Inc (LENZ) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported LENZ revenue for 2026-06-30 was $7.4M. Net income was -$73.4M. LENZ currently screens at market cap $223.6M.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
LENZ currently screens at market cap $223.6M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the LENZ and OGN stock pages for the full models.
Not investment advice.